Ankylosing spondylitis: evidence for a non-HLA-B*27 protective effect

Mapping the online manipulation economy.

Science (New York, N.Y.)·2025

Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial.

Seminars in arthritis and rheumatism·2024

The importance of cultural tailoring of communicators and media outlets in an influenza vaccination awareness campaign: a digital randomized trial.

Scientific reports·2023

Rewetting does not return drained fen peatlands to their old selves.

Nature communications·2021

The ASAS-OMERACT core domain set for axial spondyloarthritis.

Seminars in arthritis and rheumatism·2021

Communicating the effectiveness and ineffectiveness of government policies and their impact on public support: a systematic review with meta-analysis.

Royal Society open science·2020

Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies.

Annals of the rheumatic diseases·2026

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

Annals of the rheumatic diseases·2026

Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases.

Annals of the rheumatic diseases·2026

Development and validation of minimal disease activity, disease flare, and minimal clinically important difference for children with chronic nonbacterial osteomyelitis using a consensus and data-driven approach.

Annals of the rheumatic diseases·2026

Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomised, double-blind, placebo-controlled phase 3 POETYK PsA-1 trial.

Annals of the rheumatic diseases·2026

EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis.

Annals of the rheumatic diseases·2026

Recurrent laryngeal leukoplakia in a cook occupationally exposed to cooking oil fumes: a case report.

Annals of occupational and environmental medicine·2026

Death Anxiety in the Association Between Exposure-Related Burden of Patient Death and Occupational Burnout Among Healthcare Professionals: A Cross-Sectional Study.

Healthcare (Basel, Switzerland)·2026

Shift Work and Psychological Distress Among Healthcare Workers: The Mediating Role of Sleep Quality and the Association with Job Dissatisfaction.

Healthcare (Basel, Switzerland)·2026

Associated Factors and Latent Patterns of Work-Related Musculoskeletal Disorders Among Digestive Endoscopy Nurses: A Multicenter Cross-Sectional Study.

Healthcare (Basel, Switzerland)·2026

Radiation Safety Knowledge, Perceptions, and Self-Reported Practices Among Healthcare Workers in Radiology and Nuclear Medicine: A Cross-Sectional Survey.

Healthcare (Basel, Switzerland)·2026

Management of Endometriosis in the Workplaces: Preliminary Results from a Cross-Sectional Knowledge, Attitudes and Practices Study (Italy, 2026).

Healthcare (Basel, Switzerland)·2026

Related Experiment Videos

Ankylosing spondylitis: evidence for a non-HLA-B*27 protective effect

Related Concept Videos

Mapping the online manipulation economy.

Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial.

The importance of cultural tailoring of communicators and media outlets in an influenza vaccination awareness campaign: a digital randomized trial.

Rewetting does not return drained fen peatlands to their old selves.

The ASAS-OMERACT core domain set for axial spondyloarthritis.

Communicating the effectiveness and ineffectiveness of government policies and their impact on public support: a systematic review with meta-analysis.

Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies.

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseases.

Development and validation of minimal disease activity, disease flare, and minimal clinically important difference for children with chronic nonbacterial osteomyelitis using a consensus and data-driven approach.

Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomised, double-blind, placebo-controlled phase 3 POETYK PsA-1 trial.

EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis.

Recurrent laryngeal leukoplakia in a cook occupationally exposed to cooking oil fumes: a case report.

Death Anxiety in the Association Between Exposure-Related Burden of Patient Death and Occupational Burnout Among Healthcare Professionals: A Cross-Sectional Study.

Shift Work and Psychological Distress Among Healthcare Workers: The Mediating Role of Sleep Quality and the Association with Job Dissatisfaction.

Associated Factors and Latent Patterns of Work-Related Musculoskeletal Disorders Among Digestive Endoscopy Nurses: A Multicenter Cross-Sectional Study.

Radiation Safety Knowledge, Perceptions, and Self-Reported Practices Among Healthcare Workers in Radiology and Nuclear Medicine: A Cross-Sectional Survey.

Management of Endometriosis in the Workplaces: Preliminary Results from a Cross-Sectional Knowledge, Attitudes and Practices Study (Italy, 2026).

Related Experiment Videos

Ankylosing spondylitis: evidence for a non-HLA-B*27 protective effect

Related Concept Videos

Related Articles